The positron emission tomography (PET) ligand, Pittsburgh Compound-B (PiB-C11), is the most well studied amyloid imaging agent, but the short half-life of carbon-11 limits its clinical viability.

Plasma p-tau217 immunoassay offers accurate detection of Alzheimer’s disease pathology, supporting early diagnosis and ...

thh.nhs.uk The amyloidoses are a group of diseases in which amyloid, a proteinaceous substance, deposits in one or more organs. As many as 23 different precursor proteins to the formation of amyloid ...

According to Phipps, the drugs currently available to treat Alzheimer’s have only eased the symptoms rather than stop its ...

Pet insurance can absorb some of the financial impact of owning a cat or dog, whether its a broken bones or a serious illness. There are also wellness plans for routine care like vaccines and ...

Adding wellness coverage to your pet insurance plan can pay for routine costs like annual checkups, vaccinations, and flea and tick treatments, as well as one-time expenses like microchipping and ...

Further research could also help explain and even predict variation in the onset of behavioral changes in people with ...

A trial to identify fast and accurate blood tests that can diagnose dementia comes at an "exciting" time in the treatment of ...

The use of positron emission tomography (PET) in cardiology is growing rapidly. Technical features make PET a strong technology for the non-invasive evaluation of cardiac physiology. It is currently ...

Positron Energy Ltd was originally registered in the name of Positron Energy Private Limited'' and received a Certificate of Incorporation dated February 15 2008 from the Registrar of Companies ...

Dividend announcements are not available. No other corporate actions details are available.